New Hope in Cancer Treatment for Dogs: PharmaCom BioVet’s Veterinary Oncology Treatment Centers
Nov 10, 2010
Raleigh, NC, March 03, 2009 --(PR.com)-- The recently established PharmaCom BioVet Inc. (PINKSHEETS: PHMB) is making headway in opening the nation’s first branded Veterinary Oncology Treatment Centers dedicated for the care of animals and has continued to expand, giving hope to dog lovers dealing with the many forms of canine cancer.

Millions of Americans count their beloved dogs among their family members. Love for four-legged, family companions runs deep, as does the stress when animals face serious illnesses. A diagnosis of cancer causes fear and even deeper worry for most families, and the anguish of enduring a pet’s suffering and loss of the animal is tragic.

How does the family dog get treated for cancer, and how effective are any of the available treatments? Questions about the animals comfort, quality of life and prognosis for longevity are uppermost.

Recent strides in diagnostics, surgical techniques, cancer-targeting drugs, as well as radiation therapy and alternative treatments have made for more successful detection and remedies for companion dogs.

Under the management of Steve A. York, Vice President Operations and Marketing and Gary S. Berthold, President and Chief Executive Officer, PharmaCom BioVet Inc. has licensed a series of proprietary devices and compounds that will enable animals suffering from cancer to have a greater life expectancy and decreased pain.

They plan treatment centers across the U.S., starting with its flagship Missouri center.